Global CRISPR Gene Editing Market Research Report 2022 – | Business and finance


Global CRISPR Gene Editing Market to Reach $16,329.8 Million by 2031, Growing 26.4% YoY Over 2021-2031

The market driven by growing demand for better food and medical products, innovative advancements in gene therapy supported by continued investments in healthcare, growing geriatric population, and rise in genomic and chronic diseases, and the development of CRISPR-based rapid POC tests amid the COVID -19 pandemic.

The global market trend and outlook is forecasted in an optimistic, balanced and conservative view considering COVID-19. The balanced (most likely) projection is used to quantify the global CRISPR Gene Editing Market in all aspects of classification from supply, application, end-user, and the region.

  • ABCAM, Inc.
  • Agilent Technologies, Inc.
  • Applied Stem Cells, Inc.
  • Caribou Biosciences, Inc.
  • Cellecta, Inc.
  • CRISPR Therapeutics SA
  • Editas Medicine, Inc.
  • GeneCopoeia, Inc.
  • GeneScript biotechnology company
  • Horizon Discovery Group PLC
  • Integrated DNA Technologies, Inc.
  • Intellia Therapeutics Inc.
  • Lonza Group Ltd.
  • Merck KGaA
  • New England Biolabs, Inc.
  • Origin Technologies, Inc.
  • Rockland Immunochemicals, Inc.
  • Synthego Corporation
  • System Biosciences LLC
  • Takara Bio, Inc.
  • ThermoFisher Scientific, Inc.
  • ToolGen, Inc.

1.1 Industry Definition and Research Scope

2 Market Overview and Dynamics

2.1 Market Size and Forecast

2.3 Market Constraints and Challenges

2.4 Emerging Opportunities and Market Trends

2.5 Porter’s Five Forces Analysis

3 Global Market Segmentation by Supply

3.1 Market Overview by Offer

3.2.2 Databases and libraries

3.2.5 Plasmid and CRISPR vector

3.3.1 gRNA design and vector construction

3.3.2 Cell line engineering

3.3.3 Microbial gene editing

4 Global Market Segmentation by Application

4.1 Market Overview by Application

4.2 Biomedical research and therapy

4.2.4 Other biomedical applications

5 Global Market Segmentation by End User

5.1 Market Overview by End User

5.2 Pharmaceutical companies

5.3 Biotechnology companies

5.4 Academic institutions and research centers

6 Global Market Segmentation by Region

6.1 Geography Market Overview 2021-2031

6.2 2021-2031 North America Market by Country

6.2.1 North America Market Overview

6.3 Europe Market 2021-2031 by Country

6.3.1 European Market Overview

6.3.8 Rest of the European market

6.4 Asia-Pacific Market 2021-2031 by Country

6.4.1 Asia Pacific Market Overview

6.4.7 Rest of the APAC region

6.5 2021-2031 South America Market by Country

6.5.4 Rest of South America Market

6.6 MEA Market 2021-2031 by Country

6.6.4 Other national markets

7.1 Major Suppliers Overview

7.2 Launch of new products, partnership, investment and mergers and acquisitions

Laura Wood, Senior Press Officer

For EST business hours, call 1-917-300-0470

For US/CAN call toll free 1-800-526-8630

For GMT office hours call +353-1-416-8900


SOURCE: Research and Markets

Copyright BusinessWire 2022.

PUBLISHED: 01/04/2022 05:53 AM/DISC: 01/04/2022 05:53 AM

Copyright BusinessWire 2022.

Comments are closed.